Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Soft Tissue Sarcoma”

791 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 791 results

Early research (Phase 1)Looking for participantsNCT06083883
What this trial is testing

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Who this might be right for
Synovial SarcomaMyxoid/Round Cell Liposarcoma
M.D. Anderson Cancer Center 44
Large-scale testing (Phase 3)Study completedNCT02606461
What this trial is testing

Selinexor in Advanced Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Study completedNCT01755195
What this trial is testing

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
Refractory Soft Tissue Sarcomas
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Study completedNCT02672527
What this trial is testing

Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Gustave Roussy, Cancer Campus, Grand Paris 103
Not applicableStudy completedNCT04560270
What this trial is testing

CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer

Who this might be right for
Pancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors
Poitiers University Hospital 69
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Looking for participantsNCT06389799
What this trial is testing

A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

Who this might be right for
Dedifferentiated Liposarcoma
Lund University Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00441467
What this trial is testing

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eleison Pharmaceuticals LLC. 22
Testing effectiveness (Phase 2)Study completedNCT00217607
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

Who this might be right for
Sarcoma
UNICANCER 30
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01303094
What this trial is testing

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaUterine Sarcoma
Centre Oscar Lambret 53
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Very early researchUnknownNCT05961111
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Who this might be right for
SarcomaCarcinomaDigestive Cancer+7 more
Shanghai Yunying Medical Technology 20
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT00413075
What this trial is testing

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
Valerio Therapeutics 121
Testing effectiveness (Phase 2)Study completedNCT05497843
What this trial is testing

Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Who this might be right for
Soft Tissue Sarcoma
Chipscreen Biosciences, Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00509860
What this trial is testing

Irinotecan (Camptosar) in Patients With Advanced Sarcomas

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 38
Not applicableNot Yet RecruitingNCT07267780
What this trial is testing

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

Who this might be right for
Ovarian CarcinomaCervical CarcinomaEndometrial Carcinoma+3 more
National Cancer Institute, Naples 130
Next Page